Mexico
· Delayed Price · Currency is MXN Teladoc Health Statistics
Total Valuation
Teladoc Health has a market cap or net worth of MXN 26.12 billion. The enterprise value is 31.84 billion.
| Market Cap | 26.12B |
| Enterprise Value | 31.84B |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.64% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 159.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.44, with an EV/FCF ratio of 5.40.
| EV / Earnings | -1.53 |
| EV / Sales | 0.62 |
| EV / EBITDA | 35.44 |
| EV / EBIT | n/a |
| EV / FCF | 5.40 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 1.06.
| Current Ratio | 1.77 |
| Quick Ratio | 1.62 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | 35.23 |
| Debt / FCF | 5.60 |
| Interest Coverage | -8.77 |
Financial Efficiency
Return on equity (ROE) is -52.46% and return on invested capital (ROIC) is -3.73%.
| Return on Equity (ROE) | -52.46% |
| Return on Assets (ROA) | -3.30% |
| Return on Invested Capital (ROIC) | -3.73% |
| Return on Capital Employed (ROCE) | -8.11% |
| Revenue Per Employee | 10.58M |
| Profits Per Employee | -4.12M |
| Employee Count | 5,500 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 22.21 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.58% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -33.58% |
| 50-Day Moving Average | 208.38 |
| 200-Day Moving Average | 185.72 |
| Relative Strength Index (RSI) | 29.26 |
| Average Volume (20 Days) | 621 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.49 |
Income Statement
In the last 12 months, Teladoc Health had revenue of MXN 53.54 billion and -20.86 billion in losses. Loss per share was -122.32.
| Revenue | 53.54B |
| Gross Profit | 37.89B |
| Operating Income | -4.35B |
| Pretax Income | -20.71B |
| Net Income | -20.86B |
| EBITDA | 661.02M |
| EBIT | -4.35B |
| Loss Per Share | -122.32 |
Balance Sheet
The company has 27.05 billion in cash and 33.02 billion in debt, giving a net cash position of -5.97 billion.
| Cash & Cash Equivalents | 27.05B |
| Total Debt | 33.02B |
| Net Cash | -5.97B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 31.07B |
| Book Value Per Share | 179.18 |
| Working Capital | 15.05B |
Cash Flow
In the last 12 months, operating cash flow was 6.12 billion and capital expenditures -224.84 million, giving a free cash flow of 5.89 billion.
| Operating Cash Flow | 6.12B |
| Capital Expenditures | -224.84M |
| Free Cash Flow | 5.89B |
| FCF Per Share | n/a |
Margins
Gross margin is 70.76%, with operating and profit margins of -8.13% and -38.97%.
| Gross Margin | 70.76% |
| Operating Margin | -8.13% |
| Pretax Margin | -38.67% |
| Profit Margin | -38.97% |
| EBITDA Margin | 1.23% |
| EBIT Margin | -8.13% |
| FCF Margin | 11.01% |
Dividends & Yields
Teladoc Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.64% |
| Shareholder Yield | -3.64% |
| Earnings Yield | -79.88% |
| FCF Yield | 22.57% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Teladoc Health has an Altman Z-Score of -5.08. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.08 |
| Piotroski F-Score | n/a |